Orano   Report issue

For profit Phase 2
Founded: Courbevoie France (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2018
NCT03466216
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Orano Med LLC